Burning Rock Biotech (BNR) Treasury Shares (2019 - 2026)

Burning Rock Biotech (BNR) has reported Treasury Shares for 6 consecutive years, with $726.6 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Treasury Shares rose 8542.57% year-over-year to $726.6 million; the TTM figure through Mar 2026 stood at $726.6 million (up 8542.57% YoY), while the FY2025 annual figure was $8.2 million, down 5.64% from the prior year.
• Treasury Shares came in at $726.6 million for Q1 2026 at Burning Rock Biotech, up from -$8.1 million in the prior quarter.
• The five-year high for Treasury Shares was $467847.9 in Q2 2021, with the low at -$448108.7 in Q4 2022.
• Average Treasury Shares over 5 years is $179040.5, with a median of $420868.3 recorded in 2024.
• Across the five-year window, Treasury Shares plunged 1569.07% in 2023 and jumped 8542.57% in 2026, its largest moves.
• Year by year, Treasury Shares stood at $8.3 million in 2022, then advanced by 10.48% to $9.2 million in 2023, then fell by 3.77% to $8.8 million in 2024, then slumped by 191.56% to -$8.1 million in 2025, then soared by 9110.25% to $726.6 million in 2026.
• According to Business Quant data, Treasury Shares over the past three periods registered $726.6 million, -$8.1 million, and -$8.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.